BRR : 3798383
Tender Brief : Etender For The Procurement Of Anti Cancer Drugs For The Year 2023-24 , Abiraterone Acetate Tab Ip - 250 Mg , Anastrazole Tab Ip - 1Mg , Axitinib Tab - 5 Mg , Azathioprine Tab Ip - 50 Mg , Bendamustine Inj Ip - 100Mg , Bicalutamide Tab Ip - 50Mg , Bleomycin Inj Ip - 15Mg , Bortezomib Inj Ip - 2Mg , Capecitabine Tab Ip - 500Mg , Ceritinib Cap - 150 Mg , Cetuximab Inj - 100Mg , Crizotinib Cap - 250 Mg , Cyclophosphamide Tab Ip - 50Mg , Dacarbazine Inj Ip / Usp - 200Mg , Dactinomycin Inj - 0.5 Mg / 3Ml , Daunorubicin Inj Ip - 20Mg , Dexamethasone Tab Ip - 8Mg , Dexamethasone Ta... Read More
Tender Value
₹
Ref. Document
Contract Value
₹ 23,31,55,619.74
Submission Date
06-05-2023
Contract Date
15-02-2024
Completion Date
365 days
Participated Bidder List
31 No of Bidder(s)
| Sr No. | Bidder Name | Bid Analytics | Technical Bid | Financial Bid | AOC | Bid Value | Rank |
|---|---|---|---|---|---|---|---|
| 1 | cnet-technologies | Bid Analytics | 1,09,63,735.51 | L1 | |||
| 2 | cnet-technologies | Bid Analytics | |||||
| 3 | cnet-technologies | Bid Analytics | |||||
| 4 | cnet-technologies | Bid Analytics | |||||
| 5 | cnet-technologies | Bid Analytics | 2,29,23,057.72 | L1 | |||
| 6 | cnet-technologies | Bid Analytics | 78,36,628.8 | L1 | |||
| 7 | cnet-technologies | Bid Analytics | L1 | ||||
| 8 | cnet-technologies | Bid Analytics | 6,94,374.91 | L1 | |||
| 9 | cnet-technologies | Bid Analytics | 36,96,000 | L1 | |||
| 10 | cnet-technologies | Bid Analytics | 76,33,248 | L1 | |||
| 11 | cnet-technologies | Bid Analytics | 84,81,704 | L1 | |||
| 12 | cnet-technologies | Bid Analytics | L1 | ||||
| 13 | cnet-technologies | Bid Analytics | 39,56,767.22 | L1 | |||
| 14 | cnet-technologies | Bid Analytics | L1 | ||||
| 15 | cnet-technologies | Bid Analytics | 21,05,024.51 | L1 | |||
| 16 | cnet-technologies | Bid Analytics | |||||
| 17 | cnet-technologies | Bid Analytics | 3,26,54,244.03 | L1 | |||
| 18 | cnet-technologies | Bid Analytics | 1,08,60,616.48 | L1 | |||
| 19 | cnet-technologies | Bid Analytics | 2,16,26,619.58 | L1 | |||
| 20 | cnet-technologies | Bid Analytics | |||||
| 21 | cnet-technologies | Bid Analytics | |||||
| 22 | cnet-technologies | Bid Analytics | L1 | ||||
| 23 | cnet-technologies | Bid Analytics | 14,97,108.06 | L1 | |||
| 24 | cnet-technologies | Bid Analytics | 1,20,03,894 | L1 | |||
| 25 | cnet-technologies | Bid Analytics | 8,07,94,702.39 | L1 | |||
| 26 | cnet-technologies | Bid Analytics | 26,44,261.09 | L1 | |||
| 27 | cnet-technologies | Bid Analytics | 1,40,948.64 | L1 | |||
| 28 | cnet-technologies | Bid Analytics | 26,42,684.8 | L1 | |||
| 29 | cnet-technologies | Bid Analytics | |||||
| 30 | cnet-technologies | Bid Analytics | L1 | ||||
| 31 | cnet-technologies | Bid Analytics | L1 |
Work Detail
etender for the procurement of anti cancer drugs for the year 2023-24 , abiraterone acetate tab ip - 250 mg , anastrazole tab ip - 1mg , axitinib tab - 5 mg , azathioprine tab ip - 50 mg , bendamustine inj ip - 100mg , bicalutamide tab ip - 50mg , bleomycin inj ip - 15mg , bortezomib inj ip - 2mg , capecitabine tab ip - 500mg , ceritinib cap - 150 mg , cetuximab inj - 100mg , crizotinib cap - 250 mg , cyclophosphamide tab ip - 50mg , dacarbazine inj ip / usp - 200mg , dactinomycin inj - 0.5 mg / 3ml , daunorubicin inj ip - 20mg , dexamethasone tab ip - 8mg , dexamethasone tab ip - 4 mg , doxorubicin ( pegylated liposomal ) inj - 50 mg , doxorubicin liposomal inj - 20mg , enzalutamide cap - 80 mg , eribulin inj- 0.44 mg / ml , etoposide cap ip - 50mg , etoposide inj ip - 100mg , exemestane tab - 25 mg , ferric carboxymaltose inj - 1gm / 20 ml , filgrastim inj ip - 300mcg , fulvestrant inj - 250 mg , gefitinib tab ip - 250mg , ibandronate tab - 50 mg , l.asparaginase inj - 5000iu , lapatinib tab ip - 250 mg , lenvatinib cap - 4 mg , letrozole tab ip / usp - 2.5mg , megestrol acetate tab ip / bp / usp - 40 mg , melphalan tab ip - 5mg , mercaptopurine tab ip - 50 mg , mesna inj - 200mg , methotrexate inj ( intrathecal, preservative free ) - 15mg , methotrexate tab ip - 2.5mg , mitomycin for inj ip / usp - 10 mg , mitoxantrone infusion bp / usp - 20 mg , paclitaxel nanoparticle inj- 100mg , pazopanib tab - 400 mg , pegfilgrastim inj - 6mg , pomalidomide cap - 2 mg , procarbazine hcl cap ip - 50 mg , protein bound paclitaxel inj - 100 mg , rasburicase inj- 1.5 mg , regorafenib tab - 40 mg , rucaparib tab - 300 mg , sorafenib tosylate tab ip - 200mg , sunitinib cap - 12.5 mg , tamoxifen tab ip - 20mg , tegafur +uracil cap - 100 mg + 224 mg , thalidomide cap usp - 100mg , vinblastine sulphate inj ip - 10mg , vincristine sulphate inj ip / usp - 1mg , zoledronic acid inj ip - 4mg , afatinib tab - 30 mg , afatinib tab - 40 mg , bevacizumab inj - 100mg , bevacizumab inj - 400mg , carboplatin inj ip - 150mg , carboplatin inj ip - 450mg , carfilzomib inj - 60mg , carfilzomib inj - 30mg , cisplatin inj ip - 10mg , cisplatin inj ip - 50mg , cyclophosphamide inj ip - 200mg , cyclophosphamide inj ip - 500mg , cyclophosphamide inj ip -1 gm , cytarabine inj ip / bp - 100mg , dasatinib tab - 20 mg , dasatinib tab - 50 mg , decitabine inj - 50 mg , decitabine inj - 30mg , docetaxel inj ip - 20mg , docetaxel inj ip - 80mg , docetaxel inj ip - 120 mg , doxorubicin inj ( lyophilised ) ip - 10mg , doxorubicin inj ( lyophilised ) ip - 50mg , epirubicin inj ip - 10mg , epirubicin inj ip - 50mg , erlotinib tab ip - 100 mg , erlotinib tab ip - 150 mg , everolimus tab- 10 mg , everolimus tab- 5mg , flurouracil inj ip - 500mg , flurouracil inj ip - 250mg , gemcitabine inj ip - 200mg , gemcitabine inj ip - 1gm , ifosfamide with mesna inj - 1gm , ifosfamide with mesna inj - 2gm , imatinib tab ip - 100mg , imatinib tab ip - 400mg , irinotecan inj ip - 40mg , irinotecan inj ip - 100mg , lenalidomide cap - 10mg , lenalidomide cap - 25mg , leucovorin calcium inj ip - 15mg , leucovorin calcium inj ip - 50mg , leuprolide acetate inj - 3.75mg , leuprolide acetate inj - 11.25 mg , leuprolide acetate inj - 22.5 mg , methotrexateinj ip - 50mg , methotrexateinj ip - 500 mg , nilotinib cap - 150 mg , nilotinib cap -200 mg , octreotideinj - 30 mg , octreotideinj - 20mg , oxaliplatin inj ip - 50mg , oxaliplatin inj ip - 100mg , paclitaxel inj ip - 30mg , paclitaxel inj ip with codon set - 100mg , paclitaxel inj ip with codon set - 260mg , pemetrexed inj ip - 100mg , pemetrexed inj ip - 500mg , rituximab inj - 100mg , rituximab inj - 500mg , temozolomide cap ip - 100mg , temozolomide cap ip - 250 mg , trastuzumab inj - 440 mg , trastuzumab inj - 150 mg
View Original Notice/Document
Result Documents
Tender Documents
Disclaimer
We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender
✦ ✦ ✦
Awarded Bidder(s)
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
Similar Tenders Results